The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly/File Photo

(Reuters) - Pfizer Inc PFE.N is exploring sale of a group of treatments in cardiology, urology and primary care, Bloomberg reported on Thursday, citing people familiar with the matter.

The drugs could fetch more than $2 billion, Bloomberg reported. (bloom.bg/2kWj1q1)

Pfizer is working with financial adviser JPMorgan Chase & Co for the potential portfolio sale and the process is at a preliminary stage, Bloomberg said.

Pfizer could not be immediately reached for comment.